Back

Managing Ventricular Tachycardias (VT) – ablation or pacing?

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Advanced technologies for personalised disease management Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2019

About the speaker

Photo
Professor Reza Wakili

J. W. Goethe University Frankfurt, Frankfurt (Germany)

4 More presentations in this session

Presentation thumbnail
Introduction: Advanced technologies for personalised disease management.
Professor J. Le Polain de Waroux (Brugge, BE)
Video
Presentation thumbnail
Personalising Implantable Cardioverter Defibrillator (ICD) therapy for Sudden Cardiac Death (SCD) prevention.
Doctor A. D'Onofrio (Naples, IT)
Slides Video
Presentation thumbnail
Advanced technologies for managing Atrial Fibrillation (AF) and Heart Failure (HF).
Professor D. Gupta (Liverpool, GB)
Slides Video
Presentation thumbnail
Conclusion: Advanced technologies for personalised disease management.
Professor S. Willems (Hamburg, DE)
Video

Access the full session

Session thumbnail
Advanced technologies for personalised disease management

The Event

Event poster

EHRA 2019

17 March - 19 March 2019
You may be interested in
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources